Quality of Life After Conservative and Surgical Treatment of Pelvic Organ Prolapse

NCT ID: NCT04110821

Last Updated: 2024-07-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

134 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-09-15

Study Completion Date

2028-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is an observational study that gives baseline and follow-up information, that does not directly influence the allocation of patients to various treatment Options (conservative and surgical therapy of Pelvic Organ Prolapse) but the knowledge gained of the data will help to develop treatment strategies.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pelvic Organ Prolapse Quality of Life Incontinence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Pelvic Organ Prolapse (POP)

Exclusion Criteria

* \< 18 years
* Patients unable to understand an informed consent
* Patients unwilling to participate
* emergency operations
* pregnancy
* Overactive Bladder without descensus
* Stool incontinence without POP
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Basel, Switzerland

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Daniel Steinemann, PD Dr. med.

Role: PRINCIPAL_INVESTIGATOR

University Hospital Basel, Clarunis

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital Basel/Dep. of Visceral Surgery (Clarunis)

Basel, , Switzerland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Daniel C Steinemann, PD Dr. med.

Role: CONTACT

+41 61 777 75 27

Sebastian Christen

Role: CONTACT

+41 61 777 75 53

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Daniel Steinemann, PD Dr. MD

Role: primary

+41 61 777 75 27

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2019-01190

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.